Cargando…

PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE

Detalles Bibliográficos
Autores principales: Laabichi, Amine, Ammouri, Wafae, Talebi, Hasna, Mouatassim, Naima, Lachgar, Naoufal Ben, Haidouri, Soukaina, Khibri, Hajar, Harmouch, Hicham, Maamer, Mouna, Tazi-Mezalek, Zoubida, Adnaoui, Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429184/
http://dx.doi.org/10.1097/01.HS9.0000976956.94808.2f
_version_ 1785090647246503936
author Laabichi, Amine
Ammouri, Wafae
Talebi, Hasna
Mouatassim, Naima
Lachgar, Naoufal Ben
Haidouri, Soukaina
Khibri, Hajar
Harmouch, Hicham
Maamer, Mouna
Tazi-Mezalek, Zoubida
Adnaoui, Mohamed
author_facet Laabichi, Amine
Ammouri, Wafae
Talebi, Hasna
Mouatassim, Naima
Lachgar, Naoufal Ben
Haidouri, Soukaina
Khibri, Hajar
Harmouch, Hicham
Maamer, Mouna
Tazi-Mezalek, Zoubida
Adnaoui, Mohamed
author_sort Laabichi, Amine
collection PubMed
description
format Online
Article
Text
id pubmed-10429184
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104291842023-08-17 PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE Laabichi, Amine Ammouri, Wafae Talebi, Hasna Mouatassim, Naima Lachgar, Naoufal Ben Haidouri, Soukaina Khibri, Hajar Harmouch, Hicham Maamer, Mouna Tazi-Mezalek, Zoubida Adnaoui, Mohamed Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429184/ http://dx.doi.org/10.1097/01.HS9.0000976956.94808.2f Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Publication Only
Laabichi, Amine
Ammouri, Wafae
Talebi, Hasna
Mouatassim, Naima
Lachgar, Naoufal Ben
Haidouri, Soukaina
Khibri, Hajar
Harmouch, Hicham
Maamer, Mouna
Tazi-Mezalek, Zoubida
Adnaoui, Mohamed
PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title_full PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title_fullStr PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title_full_unstemmed PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title_short PB2566: EPIDEMIOLOGICAL PROFILE AND INDICATIONS FOR IV IRON THERAPY: A TRANSFUSION SPARING ALTERNATIVE
title_sort pb2566: epidemiological profile and indications for iv iron therapy: a transfusion sparing alternative
topic Publication Only
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429184/
http://dx.doi.org/10.1097/01.HS9.0000976956.94808.2f
work_keys_str_mv AT laabichiamine pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT ammouriwafae pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT talebihasna pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT mouatassimnaima pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT lachgarnaoufalben pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT haidourisoukaina pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT khibrihajar pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT harmouchhicham pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT maamermouna pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT tazimezalekzoubida pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative
AT adnaouimohamed pb2566epidemiologicalprofileandindicationsforivirontherapyatransfusionsparingalternative